This New Drug Turns Human Blood into Mosquito Killer
Scientists have developed a revolutionary drug that, when ingested, can make human blood lethal to mosquitoes, potentially opening a new front in the fight against mosquito-borne diseases such as malaria, dengue, and Zika. The breakthrough promises to reduce transmission rates significantly and protect millions of people worldwide.
According to researchers, the drug works by altering certain compounds in the blood, which are harmless to humans but deadly to mosquitoes that bite treated individuals. Early laboratory trials have shown a dramatic reduction in mosquito survival, suggesting that widespread use could help control mosquito populations in high-risk areas.
Experts highlight that this approach is unique because it targets the vector indirectly rather than using pesticides or insecticide-treated nets. By turning humans into “mosquito killers,” the drug could complement existing public health measures while reducing environmental impacts associated with traditional mosquito control methods.
Clinical trials are expected to begin soon to test safety, dosage, and long-term effects in humans. Health authorities emphasize that while promising, the drug will need rigorous evaluation before it can be deployed widely, and it will be used alongside existing prevention strategies.
Researchers remain optimistic that, if successful, this innovation could save hundreds of thousands of lives annually, particularly in regions where mosquito-borne diseases are endemic and pose a significant public health challenge.
—
خلاصہ (اردو میں):
سائنسدانوں نے ایک نیا دوا تیار کی ہے جو انسانی خون کو مچھروں کے لیے مہلک بنا دیتی ہے۔ یہ دریافت ملیریا، ڈینگی اور زیکا جیسی بیماریوں کے خلاف جدوجہد میں مددگار ثابت ہو سکتی ہے اور ہزاروں زندگیوں کو بچا سکتی ہے۔
